No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
473681 |
1. Apply sex-specific ruleNone |
473681 |
2. Check conditionsNone |
473681 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
256 |
4. Check minimum number of eventsNone |
256 |
5. Include endpointsNone |
256 |
6. Filter based on genotype QC (FinnGen only) |
250 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D18
Name in latin
Lymphangioma (quovis hoco)
Similar endpoints
↥List of similar endpoints to
Lymphangioma, anys site
based on the number of shared cases.
Similar with more cases:
- Lymphangioma, anys site
- Haemangioma and lymphangioma, any site
- Haemangioma and lymphangioma, any site
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2976 | 1458 | 1511 |
| Only index persons | 2551 | 1253 | 1298 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.04 |
| Only index persons | 0.05 | 0.05 | 0.05 |
| Median age at first event (years) | |||
| Whole population | 16.06 | 17.67 | 14.29 |
| Only index persons | 18.56 | 20.72 | 16.47 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 250 | 153 | 97 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.05 |
| Median age at first event (years) | 32.41 | 32.83 | 31.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_LYMPHANGIOMA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_LYMPHANGIOMA | 1.448 [1.07, 1.96] | 0.017 |
| Birth year | 0.992 [0.98, 1.0] | 0.092 |
During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 980 females with CD2_BENIGN_LYMPHANGIOMA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_LYMPHANGIOMA | 1.548 [1.15, 2.08] | 0.004 |
| Birth year | 0.985 [0.97, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 77 out of 1096 males with CD2_BENIGN_LYMPHANGIOMA died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_LYMPHANGIOMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.107% | 0.272% |
| 5 | 0.651% | 1.425% |
| 10 | 1.786% | 3.827% |
| 15 | 3.482% | 7.045% |
| 20 | 6.277% | 12.193% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LYMPHANGIOMA – Lymphangioma, anys site
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data